These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 2539926
1. Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertension. Seccombe DW, Pudek MR, Nowaczynski W, Humphries KH. Clin Biochem; 1989 Feb; 22(1):17-21. PubMed ID: 2539926 [Abstract] [Full Text] [Related]
2. Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma. Balzan S, Montali U, Genovesi-Ebert A, Biver P, Fantoni M, Ghione S. Clin Sci (Lond); 1989 Oct; 77(4):375-81. PubMed ID: 2553327 [Abstract] [Full Text] [Related]
3. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies. Cloix JF, Crabos M, Grichois ML, Guicheney P, Meyer P. Klin Wochenschr; 1987 Oct; 65 Suppl 8():146-53. PubMed ID: 3037183 [Abstract] [Full Text] [Related]
4. Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography. De Angelis C, Riscazzi M, Salvini R, Piccoli A, Ferri C, Santucci A. Clin Chem; 1997 Aug; 43(8 Pt 1):1416-20. PubMed ID: 9267322 [Abstract] [Full Text] [Related]
5. The contribution of steroids to digoxin-like immunoreactivity in cord blood. Yun WS, Ho CS, Panesar NS, Swaminathan R. Ann Clin Biochem; 1992 May; 29 ( Pt 3)():337-42. PubMed ID: 1319129 [Abstract] [Full Text] [Related]
6. Further biochemical characterization of an Na+ pump inhibitor purified from human urine. Crabos M, Grichois ML, Guicheney P, Wainer IW, Cloix JF. Eur J Biochem; 1987 Jan 02; 162(1):129-35. PubMed ID: 3028785 [Abstract] [Full Text] [Related]
7. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms. Butt AN, Tennant BP, Gillingwater SD, Shepherd PS, Swaminathan R. Hypertens Res; 2000 Sep 02; 23 Suppl():S45-50. PubMed ID: 11016819 [Abstract] [Full Text] [Related]
8. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction. Bagrov AYa, Fedorova OV, Maslova MN, Roukoyatkina NI, Ukhanova MV, Zhabko EP. Cardiovasc Res; 1991 May 02; 25(5):371-7. PubMed ID: 1649699 [Abstract] [Full Text] [Related]
9. Endogenous digoxin-like activity of mammalian-lignans and their derivatives. Hirano T, Oka K, Naitoh T, Hosaka K, Mitsuhashi H. Res Commun Chem Pathol Pharmacol; 1989 May 02; 64(2):227-40. PubMed ID: 2544967 [Abstract] [Full Text] [Related]
11. Ouabainlike factor in Milan hypertensive rats. Ferrandi M, Minotti E, Salardi S, Florio M, Bianchi G, Ferrari P. Am J Physiol; 1992 Oct 02; 263(4 Pt 2):F739-48. PubMed ID: 1329560 [Abstract] [Full Text] [Related]
14. A quantitative receptor assay for "digitalis-like" compounds in serum. Demonstration of raised concentrations in essential hypertension and correlation with arterial blood pressure. Moreth K, Renner D, Schoner W. Klin Wochenschr; 1987 Feb 16; 65(4):179-84. PubMed ID: 3031360 [Abstract] [Full Text] [Related]
15. Purification and characterization of human urine-derived digitalis-like factor. Goto A, Yamada K, Ishii M, Yoshioka M, Ishiguro T, Eguchi C, Sugimoto T. Biochem Biophys Res Commun; 1988 Aug 15; 154(3):847-53. PubMed ID: 2841934 [Abstract] [Full Text] [Related]
16. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients. Vasdev S, Johnson E, Longerich L, Prabhakaran VM, Gault MH. Clin Nephrol; 1987 Apr 15; 27(4):169-74. PubMed ID: 3034459 [Abstract] [Full Text] [Related]
17. Partial purification and properties of a plasma ouabain-like inhibitor of Na+, K+-ATPase in patients with essential hypertension. Masugi F, Ogihara T, Sakaguchi K, Tomii A, Hasegawa T, Chen Y, Azuma M, Kumahara Y. J Hypertens Suppl; 1988 Dec 15; 6(4):S351-3. PubMed ID: 2853743 [Abstract] [Full Text] [Related]
19. Digoxin-like immunoreactivity: is it still worth measuring? Goto A, Yamada K, Yagi N, Hui C, Sugimoto T. Life Sci; 1991 Dec 15; 49(23):1667-78. PubMed ID: 1658518 [Abstract] [Full Text] [Related]